20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7831 | Nitecapone | Others , Transferase | |
Nitecapone is a reversible inhibitor of S-COMT (IC50 values of 300 nM in rat liver) | |||
T4052 | KML29 | Lipase | |
KML29 is highly selective and effective monoacylglycerol lipase (MAGL) inhibitor. It has effective inhibition of human/mouse/rat MAGL (IC50: 5.9/15/43 nM). It has not inhibitory for FAAH (IC50 > 50 μM). It also effective... | |||
T3S2312 | Poncirin | Isosakuranetin-7-neohesperidoside | Apoptosis , Others |
1. Poncirin (Isosakuranetin-7-neohesperidoside) shows a significant in vitro inhibitory effect on the growth of the human gastric cancer cells, SGC-791, in a dose-dependent manner. 2. Poncirin prevents adipogenesis, enha... | |||
T16164 | MY-5445 | N-(3-chlorophenyl)-4-phenylphthalazin-1-amine | PDE |
MY-5445 (N-(3-chlorophenyl)-4-phenylphthalazin-1-amine) is a specific inhibitor of phosphodiesterase type 5 (PDE5). MY-5445 selectively inhibits cGMP PDE (Ki:1.3 μM). | |||
T8505 | SC-236 | Sc 236 | Apoptosis , COX , PPAR |
SC-236 (Sc 236) is an orally active and selective inhibitor of COX-2 (IC50 of 0.005 μM and 17.8 μM for COX-2 and COX-1, respectively). | |||
T4691 | Asimadoline hydrochloride | EMD-61753 hydrochloride | Opioid Receptor |
Asimadoline hydrochloride (EMD-61753 hydrochloride) is a κ-opioid receptor agonist potentially for the treatment of pruritus. Asimadoline hydrochloride has also been shown to be used in the treatment of irritable bowel s... | |||
T4633 | Asimadoline | EMD-61753 | Opioid Receptor |
Asimadoline (EMD-61753) is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline... | |||
T27405 | GAT211 | GAT-211,AZ-4,GAT 211,AZ 4,AZ4 | |
GAT211 is a CB1 positive allosteric modulator. GAT211 suppresses allodynia and produces synergistic antiallodynic effects with monoacylglycerol lipase and fatty acid amide hydrolase inhibitors in paclitaxel-treated mice. | |||
T10381 | AS2717638 | Others | |
AS2717638 is an orally active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist (IC50: 38 nM for hLPA5). It also significantly improves PGF2α-, PGE2-, and AMPA-induced allodynia. | |||
TP2068L | Cyclotraxin B acetate(1203586-72-4 free base) | Trk receptor | |
Cyclotraxin B acetate is an antagonist of TrkB receptors; inhibits BDNF-induced TrkB activity (IC50 = 0.30 nM). Allosterically alters TrkB receptor conformation but does not alter BDNF binding. Prevents BDNF-induced cold... | |||
TP1904L | FSLLRY-NH2 TFA(245329-02-6 free base) | Protease-activated Receptor | |
FSLLRY-NH2 TFA is a is a protease-activated receptor 2 (PAR2) inhibitor. Reverses taxol-induced mechanical allodynia, heat hyperalgesia and PKC activation in ICR mice. Blocks ERK activation and collagen production in iso... | |||
TP2277 | Nocistatin(human) | Nocistatin (human) | Others |
Blocker of nociceptin-induced allodynia and hyperalgesia | |||
T10209 | A-887826 | Others | |
A-887826 is a selective, orally bioavailable, and voltage-dependent Na(v1.8) channel blocker (IC50: 11 nM). It attenuates neuropathic tactile allodynia in vivo. | |||
TP2276 | Nocistatin (bovine) | Others | |
endogenous peptide used to block nociceptin-induced allodynia and hyperalgesia | |||
T27752 | KT109 | KT-109,KT 109 | |
KT109 is a selective inhibitor of DAGLβ (IC50 = 42 nM). KT109-treated wild-type mice displayed reductions in LPS-induced allodyni as well as in DAGL-β (-/-) micea. Repeated KT109 administration prevented the expression o... | |||
T61091 | P38-α MAPK-IN-4 | ||
p38-α MAPK-IN-4 (Compound 69) is a selective inhibitor of p38α MAPK, demonstrating potent inhibition with an IC50 of 1.5 μM. It effectively and swiftly mitigates the onset of mechanical allodynia (MA) in vivo [1]. | |||
TP1904 | FSLLRY-NH2 | ||
Selective PAR2 peptide antagonist. Reverses taxol-induced mechanical allodynia, heat hyperalgesia and PKC activation in ICR mice. Blocks ERK activation and collagen production in isolated cardiac fibroblasts. Also reduce... | |||
TP2068 | Cyclotraxin B | ||
Antagonist of TrkB receptors; inhibits BDNF-induced TrkB activity (IC50 = 0.30 nM). Allosterically alters TrkB receptor conformation but does not alter BDNF binding. Prevents BDNF-induced cold allodynia in mice. Also sho... | |||
T27025 | Cizolirtine citrate | E-4018,E4018,E 4018 | |
Cizolirtine is a calcitonin gene-related peptide antagonist. Cizolirtine may be useful for alleviating some neuropathic somatosensory disorders, in particular cold allodynia, with a reduced risk of undesirable side effec... | |||
T41145 | TASP 0277308 | ||
TASP 0277308 is a potent and selective sphingosine 1-phosphate 1 (S1P1) receptor antagonist (IC50 = 7.8 nM). TASP 0277308 inhibits S1P-induced chemotaxis (IC50 = 1.1-1.6 nM), HUVEC cell proliferation (IC50 = 3-3.6 nM) an... |